3-Hydroxybenzaldehyde

CAT:
804-HY-76006-01
Size:
5 g
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
3-Hydroxybenzaldehyde - image 1

3-Hydroxybenzaldehyde

  • UNSPSC Description:

    3-Hydroxybenzaldehyde (3-HBA) is a precursor compound for phenolic compounds like Protocatechuic aldehyde (PCA) (HY-N0295). 3-Hydroxybenzaldehyde, produced by 3-hydroxybenzyl-alcohol dehydrogenase, is a substrate of aldehyde dehydrogenase (ALDH) in rats and humans. 3-Hydroxybenzaldehyde has vasculoprotective effects in vitro and in vivo. 3-Hydroxybenzaldehyde is proming for research of atherosclerosis[1][2][3][4].
  • Target Antigen:

    Aldehyde Dehydrogenase (ALDH); NF-κB; p38 MAPK
  • Type:

    Natural Products
  • Related Pathways:

    MAPK/ERK Pathway;Metabolic Enzyme/Protease;NF-κB
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Inflammation/Immunology; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/3-hydroxybenzaldehyde.html
  • Purity:

    99.87
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=CC1=CC=CC(O)=C1
  • Molecular Weight:

    122.123
  • References & Citations:

    [1]Kong BS, et al. Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.PLoS One. 2016 Mar 22;11(3):e0149394.|[2]Paixão JA, et al. 3-Hydroxybenzaldehyde. Acta Crystallogr C. 2000 Nov;56 Pt 11:1348-50. |[3]Chen K Y, et al. Protective effect of benzaldehyde combined with albendazole against brain injury induced by Angiostrongylus cantonensis infection in mice[J]. International Journal of Antimicrobial Agents, 2023, 62(5): 106963.|[4]Muthu S, et al. Quantum chemical studies, vibrational analysis, molecular structure, first order hyper polarizability, NBO and HOMO-LUMO analysis of 3-hydroxybenzaldehyde and its cation[J]. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Nov;115:789-99.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, stored under nitrogen)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    100-83-4